| Baseline peripheral blood biomarkers associated with clinical outcome of advanced melanoma patients treated with ipilimumab A Martens, K Wistuba-Hamprecht, MG Foppen, J Yuan, MA Postow, ... Clinical Cancer Research 22 (12), 2908-2918, 2016 | 564 | 2016 |
| Increases in Absolute Lymphocytes and Circulating CD4+ and CD8+ T Cells Are Associated with Positive Clinical Outcome of Melanoma Patients Treated with … A Martens, K Wistuba-Hamprecht, J Yuan, MA Postow, P Wong, ... Clinical Cancer Research 22 (19), 4848-4858, 2016 | 179 | 2016 |
| Peripheral CD8 effector-memory type 1 T-cells correlate with outcome in ipilimumab-treated stage IV melanoma patients K Wistuba-Hamprecht, A Martens, F Heubach, E Romano, MG Foppen, ... European Journal of Cancer 73, 61-70, 2017 | 101 | 2017 |
| Proportions of blood-borne Vδ1+ and Vδ2+ T-cells are associated with overall survival of melanoma patients treated with ipilimumab K Wistuba-Hamprecht, A Martens, K Haehnel, MG Foppen, J Yuan, ... European Journal of Cancer 64, 116-126, 2016 | 73 | 2016 |
| The generation of CAR-transfected natural killer T cells for the immunotherapy of melanoma B Simon, M Wiesinger, J März, K Wistuba-Hamprecht, B Weide, ... International journal of molecular sciences 19 (8), 2365, 2018 | 67 | 2018 |
| Application of circulating cell-free tumor DNA profiles for therapeutic monitoring and outcome prediction in genetically heterogeneous metastatic melanoma R Váraljai, K Wistuba-Hamprecht, T Seremet, JMS Diaz, J Nsengimana, ... JCO precision oncology 3, 1-10, 2019 | 47 | 2019 |
| Age-associated alterations in γδ T-cells are present predominantly in individuals infected with Cytomegalovirus K Wistuba-Hamprecht, D Frasca, B Blomberg, G Pawelec, ... Immunity & ageing 10, 1-7, 2013 | 42 | 2013 |
| Serum CD73 is a prognostic factor in patients with metastatic melanoma and is associated with response to anti-PD-1 therapy R Turiello, M Capone, D Giannarelli, E Morretta, MC Monti, G Madonna, ... Journal for Immunotherapy of Cancer 8 (2), 2020 | 40 | 2020 |
| Establishing high dimensional immune signatures from peripheral blood via mass cytometry in a discovery cohort of stage IV melanoma patients K Wistuba-Hamprecht, A Martens, B Weide, KWW Teng, H Zelba, ... The Journal of Immunology 198 (2), 927-936, 2017 | 39 | 2017 |
| Peripheral blood T-cell signatures from high-resolution immune phenotyping of γδ and αβ T-cells in younger and older subjects in the Berlin Aging Study II K Wistuba-Hamprecht, K Haehnel, N Janssen, I Demuth, G Pawelec Immunity & Ageing 12, 1-12, 2015 | 38 | 2015 |
| Accurate quantification of T-cells expressing PD-1 in patients on anti-PD-1 immunotherapy H Zelba, J Bochem, G Pawelec, C Garbe, K Wistuba-Hamprecht, B Weide Cancer Immunology, Immunotherapy 67, 1845-1851, 2018 | 36 | 2018 |
| OMIP-020: Phenotypic characterization of human cd T-cells by multicolor flow cytometry K Wistuba-Hamprecht, G Pawelec, E Derhovanessian Cytometry A 85, 522-524, 2014 | 33 | 2014 |
| Combined treatment with ipilimumab and intratumoral interleukin-2 in pretreated patients with stage IV melanoma—safety and efficacy in a phase II study B Weide, A Martens, K Wistuba-Hamprecht, H Zelba, L Maier, HP Lipp, ... Cancer Immunology, Immunotherapy 66, 441-449, 2017 | 29 | 2017 |
| Phenotypic characterization and prognostic impact of circulating γδ and αβ T‐cells in metastatic malignant melanoma K Wistuba‐Hamprecht, S Di Benedetto, B Schilling, A Sucker, ... International Journal of Cancer 138 (3), 698-704, 2016 | 29 | 2016 |
| Vδ2+ and α/Δ T cells show divergent trajectories during human aging CTY Tan, K Wistuba-Hamprecht, W Xu, MSZ Nyunt, A Vasudev, BTK Lee, ... Oncotarget 7 (29), 44906, 2016 | 21 | 2016 |
| Peripheral PD-1+ CD56+ T-cell frequencies correlate with outcome in stage IV melanoma under PD-1 blockade J Bochem, H Zelba, T Amaral, J Spreuer, D Soffel, T Eigentler, NB Wagner, ... PLoS One 14 (8), e0221301, 2019 | 19 | 2019 |
| Tumor-derived GDF-15 blocks LFA-1 dependent T cell recruitment and suppresses responses to anti-PD-1 treatment M Haake, B Haack, T Schäfer, PN Harter, G Mattavelli, P Eiring, N Vashist, ... Nature Communications 14 (1), 4253, 2023 | 18 | 2023 |
| The predictive and prognostic significance of cell‐free DNA concentration in melanoma R Váraljai, S Elouali, SS Lueong, K Wistuba‐Hamprecht, T Seremet, ... Journal of the European Academy of Dermatology and Venereology 35 (2), 387-395, 2021 | 17 | 2021 |
| Pitfalls in the characterization of circulating and tissue-resident human γδ T cells N Beucke, D Wesch, HH Oberg, C Peters, J Bochem, B Weide, C Garbe, ... Journal of Leukocyte Biology 107 (6), 1097-1105, 2020 | 15 | 2020 |
| Immunomonitoring of human breast milk cells during HCMV-reactivation K Lazar, T Kussmann, G Pawelec, S Pöschel, R Goelz, K Hamprecht, ... Frontiers in Immunology 12, 723010, 2021 | 13 | 2021 |
